Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the addition of Patrick Daly ...

Terumo Neuro (formerly MicroVention) announced today that it received FDA premarket approval (PMA) for its Carotid Stent ...

A jury in Jefferson County on Friday morning determined that Lakewood-based Terumo Blood and Cell Technology was not negligent in the release of the chemical ethylene oxide (EtO) into the ...

Major manufacturers and startups alike brace for inflationary shock from tariffs. Here's how they're responding and how ...

Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced that their Carotid Stent System has received Premarket Approval (PMA) ...

Terumo Blood and Cell Technologies, today announced the addition of Patrick Daly as its Chief Business Officer as the company ...

Cell Technologies, today announced the addition of Patrick Daly as its Chief Business Officer as the company continues to expand its capabilities to meet evolving market segments.

"We're excited that U.S. hospitals will now have access to QFR 3.0," said Dr. Maya Barley, CEO of Medis Medical Imaging. "Our continued collaboration with Terumo Health Outcomes supports our goal of ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid st ...

April 15, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced that their Carotid Stent System has ...